Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey

JE Sharer, LA Shipley, MR Vandenbranden, SN Binkley and SA Wrighton

Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA.

The metabolism of probe substrates of phase I and phase II enzymes in vitro were compared in hepatic subcellular fractions from humans, cynomolgus monkeys, rhesus monkeys, and beagle dogs. These studies were undertaken to compare the suitability of these species as models of metabolism in drug development. Eight cytochrome P450-dependent activities were measured in microsomal incubations: ethoxyresorufin O- deethylase, coumarin 7-hydroxylase, tolbutamide 4-hydroxylase, S- mephenytoin 4'-hydroxylase, bufuralol 1'-hydroxylase, N- nitrosodimethylamine N-demethylase, midazolam 1'-hydroxylase, and erythromycin N-demethylase. Seven phase II activities were determined in the appropriate subcellular fractions:acetaminophen UDP-glucurono- syltransferase, acetaminophen sulfotransferase, 17 alpha- ethinylestradiol UDP-glucuronosyltransferase, 17 alpha-ethinylestradiol sulfotransferase, 6-mercaptopurine methylase, dichloronitrobenzene (DCNB) glutathione S-transferase, and isoniazid N-acetylase. Hepatic subcellular fractions from cynomolgus and rhesus monkeys showed significantly higher activities than those from humans for ethoxyresorufin O-deethylase, bufuralol 1'-hydroxylase, midazolam 1'- hydroxylase, erythromycin N-demethylase, acetaminophen UDP- glucuronosyltransferase, acetaminophen sulfotransferase, and tolbutamide 4-hydroxylase. Cynomolgus monkey had higher activity than humans and rhesus monkeys for S-mephenytoin 4'-hydroxylase erythromycin N-demethylase. Rhesus monkey and human cytosol displayed an apparent genetic polymorphism in the N-acetylation of isoniazid, whereas cynomolgus monkey cytosol did not. All other monkey activities were not significantly different than human. Dog subcellular fractions showed higher activity than humans for midazolam 1'-hydroxylase, erythromycin N-demethylase, acetaminophen UDP-glucuronosyltransferase, acetaminophen sulfotransferase, 17 alpha-ethinylestradiol sulfotransferase, and DCNB glutathione S-transferase. Furthermore, dog samples had significantly lower activity for coumarin 7-hydroxylase and 6-mercaptopurine methylase, and no detectable activity for tolbutamide 4-hydroxylase or isoniazid N-acetylase. All other activities were not significantly different from human. These results reveal minor differences between the cynomolgus and rhesus monkey in drug metabolism capacities in vitro, but both species are generally more metabolically active than humans in both phase I and phase II metabolism, whereas dogs had more diverse deviations from humans.

Volume 23, Issue 11, pp. 1231-1241, 11/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Y. Uno, H. Sakuraba, S. Uehara, T. Kumano, K. Matsuno, C. Nakamura, G. Kito, T. Kamataki, and R. Nagata A Null Allele Impairs Function of CYP2C76 Gene in Cynomolgus Monkeys: A Possible Genetic Tool for Generation of a Better Animal Model in Drug Metabolism Drug Metab. Dispos., January 1, 2009; 37(1): 14 - 17. [Abstract] [Full Text] [PDF]

				H. Zhang, D. Zhang, W. Li, M. Yao, C. D'Arienzo, Y.-X. Li, W. R. Ewing, Z. Gu, Y. Zhu, N. Murugesan, et al. Reduction of Site-Specific CYP3A-Mediated Metabolism for Dual Angiotensin and Endothelin Receptor Antagonists in Various in Vitro Systems and in Cynomolgus Monkeys Drug Metab. Dispos., May 1, 2007; 35(5): 795 - 805. [Abstract] [Full Text] [PDF]

				B. Carr, R. Norcross, Y. Fang, P. Lu, A. D. Rodrigues, M. Shou, T. Rushmore, and C. Booth-Genthe Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant Enzymes Drug Metab. Dispos., October 1, 2006; 34(10): 1703 - 1712. [Abstract] [Full Text] [PDF]

				I. J. Martin, R. J. Lewis, M. A. Bernstein, I. G. Beattie, C. A. Martin, R. J. Riley, and B. Springthorpe Which Hydroxy? Evidence for Species Differences in the Regioselectivity of Glucuronidation in Rat, Dog, and Human in Vitro Systems and Dog in Vivo Drug Metab. Dispos., September 1, 2006; 34(9): 1502 - 1507. [Abstract] [Full Text] [PDF]

				T. Prueksaritanont, Y. Kuo, C. Tang, C. Li, Y. Qiu, B. Lu, K. Strong-Basalyga, K. Richards, B. Carr, and J. H. Lin In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies Drug Metab. Dispos., September 1, 2006; 34(9): 1546 - 1555. [Abstract] [Full Text] [PDF]

				Y. Uno, H. Fujino, G. Kito, T. Kamataki, and R. Nagata CYP2C76, a Novel Cytochrome P450 in Cynomolgus Monkey, Is a Major CYP2C in Liver, Metabolizing Tolbutamide and Testosterone Mol. Pharmacol., August 1, 2006; 70(2): 477 - 486. [Abstract] [Full Text] [PDF]

				L. Gu, S. E. House, R. L. Prior, N. Fang, M. J. J. Ronis, T. B. Clarkson, M. E. Wilson, and T. M. Badger Metabolic Phenotype of Isoflavones Differ among Female Rats, Pigs, Monkeys, and Women J. Nutr., May 1, 2006; 136(5): 1215 - 1221. [Abstract] [Full Text] [PDF]

				J. R. Foster Spontaneous and Drug-Induced Hepatic Pathology of the Laboratory Beagle Dog, the Cynomolgus Macaque and the Marmoset Toxicol Pathol, January 1, 2005; 33(1): 63 - 74. [Abstract] [Full Text] [PDF]

				R. L. Walsky and R. S. Obach VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES Drug Metab. Dispos., June 1, 2004; 32(6): 647 - 660. [Abstract] [Full Text] [PDF]

				N. J Hewitt and D. Utesch Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures Human and Experimental Toxicology, June 1, 2004; 23(6): 307 - 316. [Abstract] [PDF]

				K. K. A. Van Rompay, L. L. Brignolo, D. J. Meyer, C. Jerome, R. Tarara, A. Spinner, M. Hamilton, L. L. Hirst, D. R. Bennett, D. R. Canfield, et al. Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1469 - 1487. [Abstract] [Full Text] [PDF]

				K. A. Schoedel, E. M. Sellers, R. Palmour, and R. F. Tyndale Down-Regulation of Hepatic Nicotine Metabolism and a CYP2A6-Like Enzyme in African Green Monkeys after Long-Term Nicotine Administration Mol. Pharmacol., January 1, 2003; 63(1): 96 - 104. [Abstract] [Full Text] [PDF]

				J. Tibbitts Issues Related to the Use of Canines in Toxicologic Pathology--Issues With Pharmacokinetics and Metabolism Toxicol Pathol, January 1, 2003; 31(1_suppl): 17 - 24. [Abstract] [PDF]

				M. G. Soars, B. Burchell, and R. J. Riley In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 382 - 390. [Abstract] [Full Text] [PDF]

				J. Sahi, E. L. Reyner, J. N. Bauman, K. Gueneva-Boucheva, J. E. Burleigh, and V. H. Thomas The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs Drug Metab. Dispos., February 1, 2002; 30(2): 135 - 140. [Abstract] [Full Text] [PDF]

				O. Barbier, C. Albert, I. Martineau, M. Vallée, K. High, F. Labrie, D. W. Hum, C. Labrie, and A. Bélanger Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes Mol. Pharmacol., March 1, 2001; 59(3): 636 - 645. [Abstract] [Full Text]

				M. G. Soars, R. J. Riley, K. A. B. Findlay, M. J. Coffey, and B. Burchell Evidence for Significant Differences in Microsomal Drug Glucuronidation by Canine and Human Liver and Kidney Drug Metab. Dispos., February 1, 2001; 29(2): 121 - 126. [Abstract] [Full Text]

				T. Mushiroda, R. Douya, E. Takahara, and O. Nagata The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate Drug Metab. Dispos., October 1, 2000; 28(10): 1231 - 1237. [Abstract] [Full Text] [PDF]

				M. D. Perloff, L. L. von Moltke, M. H. Court, T. Kotegawa, R. I. Shader, and D. J. Greenblatt Midazolam and Triazolam Biotransformation in Mouse and Human Liver Microsomes: Relative Contribution of CYP3A and CYP2C Isoforms J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 618 - 628. [Abstract] [Full Text]

				W. Tang, R. A. Stearns, G. Y. Kwei, S. A. Iliff, R. R. Miller, M. A. Egan, N. X. Yu, D. C. Dean, S. Kumar, M. Shou, et al. Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1068 - 1074. [Abstract] [Full Text]

				S. K. Paulson, L. Engel, B. Reitz, S. Bolten, E. G. Burton, T. J. Maziasz, B. Yan, and G. L. Schoenhard Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib Drug Metab. Dispos., October 1, 1999; 27(10): 1133 - 1142. [Abstract] [Full Text]

				A. D. M. Kashuba, J. R. Dyer, L. M. Kramer, R. H. Raasch, J. J. Eron, and M. S. Cohen Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1 Antimicrob. Agents Chemother., August 1, 1999; 43(8): 1817 - 1826. [Full Text]

				G. N. Kumar, V. Jayanti, R. D. Lee, D. N. Whittern, J. Uchic, S. Thomas, P. Johnson, B. Grabowski, H. Sham, D. Betebenner, et al. In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification Drug Metab. Dispos., January 1, 1999; 27(1): 86 - 91. [Abstract] [Full Text]

				G. Amato, V. Longo, A. Mazzaccaro, and P. G. Gervasi Chlorzoxazone 6-Hydroxylase and p-Nitrophenol Hydroxylase as the Most Suitable Activities for Assaying Cytochrome P450 2E1 in Cynomolgus Monkey Liver Drug Metab. Dispos., May 1, 1998; 26(5): 483 - 489. [Abstract] [Full Text]

				N. Chauret, A. Gauthier, J. Martin, and D. A. Nicoll-Griffith In Vitro Comparison of Cytochrome P450-Mediated Metabolic Activities in Human, Dog, Cat, and Horse Drug Metab. Dispos., October 1, 1997; 25(10): 1130 - 1136. [Abstract] [Full Text]

				E. A. Oddy, G. R. Manchee, N. M. Freeman, M. A. Ward, and M. W. H. Coughtrie Purification and Characterization of a Canine Liver Phenol Sulfotransferase Drug Metab. Dispos., October 1, 1997; 25(10): 1205 - 1210. [Abstract] [Full Text]